|
US3965256A
|
|
Slow release pharmaceutical compositions
|
|
US3886268A
|
|
Iodophor-steroid compound pharmaceutical compositions
|
|
CA986412A
|
|
Iodophor-steroid pharmaceutical compositions
|
|
US3734734A
|
|
Deproteinizing protein-containing solutions
|
|
US3772442A
|
|
Magnesium phenolic laxative compositions and methods of use
|
|
CA931579A
|
|
Anthrone oxime compounds
|
|
CA950826A
|
|
Mite antigen and process for its manufacture
|
|
US3595750A
|
|
Process of making magnesium phenolic laxative compound
|
|
US3526635A
|
|
Magnesium complex of dihydroxydiphenyl-isatin,4,4-dehydroxydiphenyl (2-pyridyl) methane,4,4'-dihydroxydiphenyl-2' - (aminophenyl methane) and phenophthalein
|
|
US3608086A
|
|
Treatment of dermatologic diseases employing aluminum propionate aluminum dipropionate and certain double acid salts thereof
|
|
CA870605A
|
|
Sennoside derivatives
|
|
CA779301A
|
|
Amine salts of pyrrolidone carboxylic acid
|
|
CA831518A
|
|
Anthraquinone derivatives
|
|
CA784758A
|
|
Aluminum propionate compositions
|
|
CA621523A
|
|
Gall-bladder preparation
|
|
CA662558A
|
|
Quinidine galacturonates
|
|
CA702773A
|
|
Oral analgesic preparation
|
|
CA715077A
|
|
Sennoside-complex
|
|
CA739971A
|
|
Hydrazine derivatives
|
|
CA647486A
|
|
Betaine glutamate
|
